<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02655029</url>
  </required_header>
  <id_info>
    <org_study_id>IC4-06593-021-GRC</org_study_id>
    <nct_id>NCT02655029</nct_id>
  </id_info>
  <brief_title>Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination</brief_title>
  <acronym>CONTROL-3</acronym>
  <official_title>Prospective, Non-interventional Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination, in a Greek Population With Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Servier Hellas Pharmaceuticals Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Servier Hellas Pharmaceuticals Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to record, in routine clinical practice, patients'
      adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination, during
      4 months treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a non-interventional study aiming to record adherence to treatment with
      Perindopril/Indapamide/Amlodipine fixed dose combination. In parallel blood pressure levels
      will be recorded, as well as safety and tolerability of this fixed dose combination.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 25, 2015</start_date>
  <completion_date type="Actual">December 21, 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>4 Months</target_duration>
  <primary_outcome>
    <measure>Adherence to treatment</measure>
    <time_frame>Change of total score of compliance scale between baseline and 1st month and between 1st and 4th month of treatment</time_frame>
    <description>Total score of Hill-Bone High Blood Pressure Compliance Scale will be recorded at each study visit</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>All visits (baseline, 1st and 4th month of treatment)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>All visits (baseline, 1st and 4th month of treatment)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events recording leading to treatment discontinuation</measure>
    <time_frame>1st and 4th month of treatment</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">2285</enrollment>
  <condition>Adherence to Medication Regime</condition>
  <condition>Hypertensive Disease</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Perindopril/Indapamide/Amlodipine fixed dose combination</intervention_name>
    <description>Dose selection is based on investigators management.</description>
    <other_name>Triplixam</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Greek patients with arterial hypertension who receive treatment with
        Perindopril/Indapamide/Amlodipine fixed dose combination.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female, ambulatory patients &gt;18 years old.

          -  Clinically diagnosed essential arterial hypertension.

          -  Under treatment with Perindoril/Indapamide/Amlodipine fixed dose combination.

          -  The patient has given his/her written consent after being informed, before his
             inclusion in the study.

        Exclusion Criteria:

          -  Secondary arterial hypertension.

          -  Serious end stage diseases, severe neuropsychiatric diseases, cerebrovascular event
             with serious residual lesions, scheduled procedure or surgical operation or hospital
             admission.

          -  Pregnancy, lactation or intention to become pregnant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Konstantinos Tsioufis, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ippokrateion General Hospital of Athens</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ippokratio University Hospital of Athens</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2016</study_first_submitted>
  <study_first_submitted_qc>January 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2016</study_first_posted>
  <last_update_submitted>March 23, 2017</last_update_submitted>
  <last_update_submitted_qc>March 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amlodipine</mesh_term>
    <mesh_term>Perindopril</mesh_term>
    <mesh_term>Indapamide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

